Creutzfeldt-Jakob disease: Difference between revisions
No edit summary |
(Undo revision 1621375 by Sahar Memar Montazerin (talk)) Tag: Undo |
||
| Line 2: | Line 2: | ||
{{Creutzfeldt-Jakob disease}} | {{Creutzfeldt-Jakob disease}} | ||
{{CMG}}; {{AE}}, | {{CMG}}; {{AE}}{{sali}}, {{MMJ}} | ||
==[[Creutzfeldt-Jakob disease overview|Overview]]== | ==[[Creutzfeldt-Jakob disease overview|Overview]]== | ||
Revision as of 21:22, 4 July 2020
|
Creutzfeldt-Jakob disease Microchapters |
|
Differentiating Creutzfeldt-Jakob disease from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Creutzfeldt-Jakob disease On the Web |
|
American Roentgen Ray Society Images of Creutzfeldt-Jakob disease |
|
Risk calculators and risk factors for Creutzfeldt-Jakob disease |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Syed Musadiq Ali M.B.B.S.[2], Mohamadmostafa Jahansouz M.D.[3]
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Creutzfeldt-Jakob disease from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic study of choice | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X-Ray Findings | Echocardiography and Ultrasound | CT-Scan Findings | MRI Findings | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Interventions | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies